h
g
h
l
g
h
pcmv
plhv
hev
perv
identifi
main
risk
factor
xenotransplant
detect
method
elimin
program
pcmv
plhv
hev
develop
perv
integr
genom
pig
infect
human
cell
vitro
strategi
prevent
perv
transmiss
also
develop
xenotransplant
use
pig
cell
tissu
organ
overcom
three
hurdl
appli
clinic
treatment
organ
failur
immunolog
reject
physiolog
incompat
transfer
infecti
agent
microbiolog
safeti
xenotransplant
import
issu
howev
manag
easili
risk
infect
also
known
allotransplant
numer
infecti
agent
transmit
togeth
human
donor
transplant
includ
human
cytomegaloviru
hcmv
human
immunodefici
rabi
viru
sinc
xenotransplant
allow
screen
donor
anim
beforehand
risk
exclud
care
test
xenotransplant
final
microbiolog
safer
technolog
compar
allotransplant
like
anim
pig
carri
numer
microorgan
digest
tract
skin
therefor
cell
tissu
organ
use
transplant
remov
asept
condit
number
microorgan
present
tissu
organ
interest
zero
review
concern
microbiolog
safeti
xenotransplant
numer
microorgan
list
thought
induc
zoonos
transmit
human
recipi
zoonosi
mean
microorgan
infect
new
host
caus
diseas
gener
bacteria
fungi
parasit
virus
may
transmit
howev
present
rather
difficult
classifi
porcin
microorgan
pathogen
nonpathogen
human
recipi
addit
microorgan
pathogen
pig
mean
also
pathogen
human
vice
versa
risk
transmiss
certainli
higher
pharmaceut
immunosuppress
prevent
immunolog
reject
transplant
appli
therefor
still
unclear
microorgan
monitor
auckland
island
pig
use
first
clinic
trial
perform
new
zealand
compani
lct
screen
regularli
bacteria
virus
toxoplasma
tabl
ottingen
minipig
use
numer
biomed
investig
screen
regularli
bacteria
virus
three
fungi
four
parasit
httpwwwminipigsdk
addit
screen
ottingen
minipig
involv
perv
hepat
e
microorgan
gener
microorgan
found
pig
use
xenotransplant
may
elimin
specifi
pathogen
free
spf
design
pathogenfre
dpf
breed
anim
case
bacteri
fungal
infect
donor
pig
treatment
antibiot
chemotherapeut
may
success
moment
hepat
e
viru
hev
porcin
cytomegaloviru
pcmv
porcin
circovirus
pcv
porcin
lymphotrop
herp
virus
plhv
porcin
endogen
retrovirus
perv
thought
pose
main
risk
reason
discuss
therefor
microorgan
analys
next
chapter
detail
case
hev
caus
selflimit
hepat
human
wherea
hev
genotyp
gt
found
peopl
transmit
mainli
contamin
water
caus
high
mortal
pregnanc
hev
swine
virus
caus
diseas
pig
howev
infect
human
may
caus
rare
case
zoonot
diseas
review
see
sever
hepat
infect
hev
observ
case
underli
liver
diseas
importantli
neurolog
disord
also
describ
hev
note
hev
may
pose
risk
xenotransplant
use
pig
cell
tissu
organ
perform
usual
hev
transmit
contamin
meat
direct
contact
infect
pig
hev
rna
detect
pig
liver
groceri
store
infecti
viru
could
isol
hev
transmiss
shellfish
veget
possibl
contamin
pig
manur
well
blood
transfus
allotransplant
also
report
chronic
infect
like
develop
immunosuppress
patient
includ
infect
individu
sensit
pcrbase
method
develop
determin
hev
infect
genotyp
viru
detect
hev
elimin
pig
seem
easi
first
viru
heterogen
eg
subtyp
genotyp
exist
make
difficult
design
effici
pcr
realtim
pcr
second
viru
load
seem
low
even
highli
sensit
pcr
may
unabl
detect
viru
although
hev
wide
distribut
preval
pig
especi
multitransgen
pig
gener
usag
xenotransplant
well
studi
contrast
nontransgen
auckland
island
pig
gener
live
cell
technolog
lct
new
zealand
better
tabl
microorgan
test
auckland
island
pig
use
islet
cell
transplant
although
hev
common
pig
new
zealand
auckland
island
pig
free
hev
anoth
well
investig
breed
ottingen
minipig
produc
ellegaard
denmark
anim
use
worldwid
numer
biomed
investig
herd
establish
entri
anim
obtain
caesarean
section
colostrum
depriv
despit
hev
found
one
studi
anim
anoth
use
realtim
pcr
western
blot
analysi
detect
antibodi
hev
hev
found
anim
result
suggest
transplacent
mothertopiglet
transmiss
viru
observ
may
help
explain
viru
enter
pig
herd
despit
caesarean
section
precaut
remain
unclear
whether
absenc
viru
older
ottingen
minipig
due
elimin
viru
possibl
immun
system
due
limit
detect
method
order
elimin
hev
herd
hev
elimin
program
propos
fig
elimin
includ
select
hev
neg
anim
use
highli
sensit
realtim
pcr
sinc
clear
whether
anim
truli
neg
carri
hev
concentr
sensit
detect
method
treatment
step
includ
use
ribavirin
guanosin
analogu
use
stop
viral
rna
synthesi
although
data
treatment
hev
infect
ribavirin
pig
ribavirin
success
use
treatment
viru
infect
pig
anoth
strategi
may
includ
vaccin
step
eg
use
vaccin
base
recombin
fragment
hev
approv
chines
fda
sinc
hev
repres
one
serotyp
induc
antibodi
protect
infect
genotyp
immunis
pig
pig
hev
result
effect
protect
indic
pig
immun
mount
effect
antivir
immun
respons
human
cytomegaloviru
hcmv
caus
sever
transplant
reject
allotransplant
consider
concern
warrant
potenti
pathogen
porcin
cytomegaloviru
pcmv
set
xenotransplant
pcmv
endem
world
pig
popul
acquir
earli
life
pcmv
infect
result
seroconvers
lifelong
latent
infect
pcmv
spread
vertic
horizont
transmiss
activ
infect
caus
fatal
system
failur
piglet
less
week
age
clinic
symptom
infect
piglet
includ
pneumonia
inclus
bodi
rhiniti
high
mortal
rate
pcmvinfect
sow
prone
abort
patholog
chang
includ
edema
heart
organ
pcmv
remain
latent
adult
pig
ubiquit
natur
herpesvirus
includ
pcmv
mean
virus
major
focu
develop
xenotransplant
herpesvirus
abl
infect
speci
porcin
cell
infect
hcmv
indic
pig
transplant
may
infect
recipi
hcmv
posit
pcmv
infect
human
cell
entri
hcmv
porcin
endotheli
cell
depend
cellular
vascular
origin
viral
strain
pcmv
transmit
pig
transplant
baboon
baboon
cmv
activ
caus
invas
diseas
consumpt
coagulopathi
pcmv
mainli
replic
pig
transplant
caus
ureter
necrosi
one
transplant
baboon
receiv
pig
kidney
pcmvinfect
pig
surviv
time
day
comparison
day
organ
uninfect
anim
transplant
similar
experi
cynomolgu
monkey
differ
day
versu
day
alon
presenc
viru
import
influenc
transplant
surviv
larg
white
pig
analyz
anim
found
posit
pcmv
howev
specifi
pathogen
free
spf
design
pathogenfre
dpf
condit
pcmvfree
anim
obtain
indic
select
pcmvfree
anim
caesarean
deliveri
spf
breed
possibl
hand
due
reactiv
baboon
cmv
pig
cardiac
xenotransplant
pharmaceut
immunosuppress
lethal
outcom
case
observ
despit
prophylact
treatment
antivir
drug
ganciclovir
valganciclovir
auckland
island
pig
alreadi
use
clinic
islet
cell
transplant
shown
free
pcmv
mention
pcmv
elimin
easili
caesarean
deliveri
dpf
spf
breed
herd
addit
earli
wean
piglet
sow
erad
cmv
safer
site
treatment
antivir
drug
ganciclovir
cidofovir
foscarnet
acyclovir
valaciclovir
prodrug
acyclovir
valganciclovir
includ
elimin
protocol
fig
concern
vaccin
hcmv
despit
urgent
need
allotranspl
recipi
success
report
although
first
attempt
use
major
envelop
glycoprotein
gb
demonstr
efficaci
hcmv
infect
hcmvinduc
diseas
immun
studi
gb
protein
pcmv
perform
pig
porcin
lymphotrop
herpesviru
plhv
common
porcin
virus
howev
preval
import
virus
xenotransplant
well
studi
phylogenet
analys
show
three
phlv
cluster
togeth
rumin
gammaherpesvirus
distantli
relat
transmiss
phlv
pig
well
understood
plhv
may
fig
schemat
present
propos
viru
elimin
program
origin
herd
screen
presenc
put
zoonot
viru
grey
posit
anim
pink
neg
anim
neg
anim
may
actual
posit
detect
limit
select
use
caesarean
deliveri
treatment
antivir
drug
andor
vaccin
truli
neg
anim
could
obtain
use
breed
xenotransplant
transmit
prepartum
crossplacent
vertic
transfer
postpartum
horizont
transmiss
howev
crossplacent
transfer
common
way
anim
differ
herd
germani
ireland
franc
spain
unit
state
infect
one
plhv
contrast
pcmv
earli
wean
erad
phlv
circovirus
belong
smallest
virus
replic
autonom
mammalian
cell
porcin
circoviru
link
diseas
wherea
caus
agent
postwean
multisystem
wast
syndrom
pmw
multifactori
diseas
pig
mean
presenc
viru
necessari
diseas
requir
addit
factor
onset
diseas
sever
symptom
influenc
statu
immun
system
genet
predisposit
characterist
clinic
sign
pmw
wast
respiratori
dysfunct
enlarg
inguin
lymph
node
diarrhoea
generalis
deplet
lymphocyt
although
human
ingest
pcvcontamin
food
expos
pcv
sourc
serolog
evid
indic
transmiss
human
took
place
also
contamin
human
vaccin
pcv
shown
transmit
pcv
human
retrospect
test
confirm
presenc
dna
rotarix
oral
liveattenu
human
rotaviru
vaccin
children
begin
initi
stage
develop
vaccin
lot
use
clinic
studi
conduct
preand
postlicensur
human
cell
line
infect
persist
cell
line
without
caus
visibl
chang
cell
show
cytopathogen
effect
importantli
infect
nonproduct
porcin
endogen
retrovirus
result
transspeci
transmiss
retroviru
integr
genom
pig
perva
pervb
polytrop
virus
infect
also
human
cell
review
see
pervc
infect
pig
cell
present
pig
wherea
transform
human
cell
lack
intracellular
restrict
factor
abopec
infect
easili
human
primari
cell
infect
hightitr
perva
recombin
pervac
adapt
human
cell
lead
increas
number
transcript
factor
bind
site
long
termin
repeat
sinc
pervc
present
mani
pig
select
pig
carri
pervc
provirus
automat
prevent
gener
hightitr
recombin
perva
c
transmiss
perv
observ
neither
first
clinic
trial
enrol
patient
preclin
pig
nonhuman
primat
transplant
infect
experi
small
anim
nonhuman
primat
without
pharmaceut
immunosuppress
review
see
howev
patient
clinic
trial
expos
long
time
xenotranspl
except
associ
parallel
kidney
allotransplant
pharmaceut
immunosuppress
appli
addit
transmiss
perv
observ
numer
pig
nonhuman
primat
transplant
howev
meanwhil
clear
nonhuman
primat
suitabl
model
studi
question
sinc
nonhuman
primat
carri
e
contrast
human
e
mutat
receptor
perv
allow
infect
low
effici
therefor
question
whether
perv
may
transmit
xenotransplant
still
open
elimin
infecti
provirus
advis
sinc
retrovirus
may
induc
tumour
immunodefici
perv
close
relat
gammaretrovirus
felin
leukaemia
viru
felv
murin
leukaemia
viru
mulv
koala
retroviru
korv
relat
virus
induc
sever
immunodefici
tumour
infect
host
gammaretrovirus
use
vector
gene
therapi
treatment
sever
combin
immunodefici
children
shown
induc
leukaemia
patient
indic
transspeci
transmiss
gammaretrovirus
human
may
induc
tumour
develop
highli
sensit
specif
method
develop
screen
preval
express
perv
donor
pig
wherea
express
perv
german
landrac
pig
rel
low
express
yucatan
minipig
high
anim
viral
protein
may
detect
differ
tissu
anim
infecti
viru
found
releas
stimul
peripher
blood
mononuclear
cell
pbmc
cross
landrac
pig
minipig
increas
express
rate
perv
ottingen
minipig
screen
rel
low
express
releas
viru
particl
observ
elimin
program
hev
pcmv
describ
detail
elimin
program
microorgan
except
perv
see
similarli
includ
screen
donor
pig
use
specif
sensit
method
treatment
antivir
drug
immunis
fig
porcin
microorgan
effect
vaccin
avail
exampl
circovirus
ingelvac
circoflex
mycoplasma
ingelvac
circoflex
sever
vaccin
avail
treat
pig
prevent
transmiss
infecti
agent
tabl
howev
vaccin
necessari
infecti
agent
present
pig
herd
pose
risk
transplant
recipi
case
bacteria
consid
whether
donor
pig
case
also
recipi
treat
antibiot
sinc
perv
present
genom
pig
elimin
way
microorgan
elimin
easili
strategi
develop
prevent
transmiss
infecti
agent
first
anim
low
copi
number
perv
low
express
rate
select
second
anim
carri
pervc
select
order
prevent
perva
c
recombin
third
transgen
pig
gener
express
small
interf
rna
specif
inhibit
express
perv
therefor
lower
probabl
perv
transmiss
sinc
genom
pig
multipl
perv
provirus
found
sometim
elimin
perv
copi
genom
edit
use
zinc
finger
nucleas
zfn
may
difficult
select
zfn
specif
sequenc
highli
conserv
pol
region
viru
howev
first
attempt
elimin
perv
pig
genom
fail
obvious
due
strong
toxic
effect
zfn
cut
genom
multipl
site
therefor
destabilis
genom
lower
concentr
zfn
gradual
elimin
may
altern
strategi
addit
new
attempt
use
cluster
regularli
interspac
short
palindrom
repeatscrisprassoci
gene
edit
undertaken
goal
elimin
least
replic
compet
provirus
fourth
last
least
transmiss
perv
may
prevent
vaccin
immunis
differ
anim
speci
goat
rat
mice
hamster
guinea
pig
recombin
transmembran
envelop
protein
surfac
envelop
protein
perv
alway
effect
neutralis
antibodi
induc
result
immunis
transmembran
envelop
protein
great
interest
case
neutralis
antibodi
obtain
one
epitop
recognis
localis
membran
proxim
extern
region
mper
fusion
peptid
proxim
region
epitop
mper
localis
similarli
correspond
epitop
recognis
antibodi
broadli
neutralis
isol
infect
individu
transmembran
envelop
protein
despit
evolutionari
differ
perv
three
ident
amino
acid
detect
epitop
immunis
surfac
envelop
protein
induc
higher
titr
neutralis
antibodi
compar
immunis
transmembran
envelop
protein
sinc
anim
model
allow
analys
effici
perv
vaccin
vivo
relat
felv
studi
cat
immunis
recombin
felv
neutralis
antibodi
detect
epitop
recognis
similarli
locat
compar
epitop
recognis
antibodi
neutralis
perv
immunis
cat
challeng
infecti
felv
anim
protect
suggest
case
perv
vaccin
may
also
work
data
indic
immunis
transplant
recipi
may
success
case
prevent
strategi
work
